Exploring how natriuretic peptide-guided therapy is revolutionizing chronic heart failure treatment through biomarker-driven precision medicine.
Discover how Left Ventricular Assist Devices (LVADs) are transforming end-stage heart failure treatment by enabling genuine myocardial recovery.
Exploring the role of background calcium influx in heart failure-associated calcium waves and potential regenerative therapies.
Discover how pharmacogenomics is revolutionizing heart failure treatment by personalizing carvedilol therapy based on genetic markers and miRNA profiles.
Explore groundbreaking drug treatments transforming chronic cardiopulmonary disease management, including SGLT2 inhibitors, ARNIs, and advanced pulmonary vasodilators.
Discover how Venenum Bufonis, a traditional Chinese medicine derived from toad venom, is being studied through network pharmacology and molecular docking for heart failure treatment.